Journal of Antimicrobial Chemotherapy · 1983 · 29 citations · 9 references
Veterinary MedicineInfectious DiseasesPharmacotherapyAntimicrobial PharmacologyAntimicrobial PharmacotherapyAntimicrobial ResistanceAntibiotic ResistanceAntimicrobial DosingAntimicrobial TherapyBacterial InfectionsBacterial Infection TreatmentBacteroides SpeciesCeftriaxone TherapyCephalosporin ResistanceCephalosporin TherapyPseudomonas SpeciesSerious Bacterial InfectionSpectrum Of Cephalosporins
Ceftriaxone, a broad spectrum cephalosporin with a markedly extended half-life, was administered to 68 patients with 71 infections in an open trial. Sixty-three infections (89%) had a satisfactory clinical response with eradication of bacteria present at the initiation of therapy in 62 infections (87%). The eight treatment failures correlated well with the development of resistance to ceftriaxone during therapy in Enterobacter and Pseudomonas species (two cases) and with superinfection with Bacteroides fragilis (three cases). Treatment was discontinued in eight patients because of unwanted effects. Serious side effects included leukopenia, rash, fever, and enterocolitis.
9
Simplified, Accurate Method for Antibiotic Assay of Clinical Specimens
John V. Bennett, Jean L. Brodie, E. Jack Benner et al. · Applied Microbiology · 1966 · 922 citations · Full text
Intravenous Antibiotic Therapy in an Outpatient Setting
Donald M. Poretz · JAMA · 1982 · 152 citations
Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporin
M Seddon, Robert A. Wise, A.P. Gillett et al. · Antimicrobial Agents and Chemotherapy · 1980 · 105 citations · Full text